chrX-38352649-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000531.6(OTC):c.-48G>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00083 in 1,013,723 control chromosomes in the GnomAD database, including 2 homozygotes. There are 278 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00086 ( 0 hom., 45 hem., cov: 23)
Exomes 𝑓: 0.00083 ( 2 hom. 233 hem. )
Consequence
OTC
NM_000531.6 5_prime_UTR
NM_000531.6 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.77
Genes affected
OTC (HGNC:8512): (ornithine transcarbamylase) This nuclear gene encodes a mitochondrial matrix enzyme. The encoded protein is involved in the urea cycle which functions to detoxify ammonia into urea for excretion. Mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant X-38352649-G-T is Benign according to our data. Variant chrX-38352649-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 368256.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.000826 (745/901940) while in subpopulation EAS AF= 0.00346 (101/29200). AF 95% confidence interval is 0.00291. There are 2 homozygotes in gnomad4_exome. There are 233 alleles in male gnomad4_exome subpopulation. Median coverage is 15. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 45 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OTC | NM_000531.6 | c.-48G>T | 5_prime_UTR_variant | 1/10 | ENST00000039007.5 | ||
OTC | NM_001407092.1 | c.-48G>T | 5_prime_UTR_variant | 3/12 | |||
OTC | XM_017029556.2 | c.-48G>T | 5_prime_UTR_variant | 1/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OTC | ENST00000039007.5 | c.-48G>T | 5_prime_UTR_variant | 1/10 | 1 | NM_000531.6 | P1 | ||
OTC | ENST00000488812.1 | n.45G>T | non_coding_transcript_exon_variant | 1/6 | 5 | ||||
OTC | ENST00000643344.1 | c.-48G>T | 5_prime_UTR_variant, NMD_transcript_variant | 1/11 |
Frequencies
GnomAD3 genomes AF: 0.000868 AC: 97AN: 111727Hom.: 0 Cov.: 23 AF XY: 0.00133 AC XY: 45AN XY: 33891
GnomAD3 genomes
AF:
AC:
97
AN:
111727
Hom.:
Cov.:
23
AF XY:
AC XY:
45
AN XY:
33891
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00143 AC: 256AN: 179277Hom.: 1 AF XY: 0.00120 AC XY: 77AN XY: 64121
GnomAD3 exomes
AF:
AC:
256
AN:
179277
Hom.:
AF XY:
AC XY:
77
AN XY:
64121
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000826 AC: 745AN: 901940Hom.: 2 Cov.: 15 AF XY: 0.000897 AC XY: 233AN XY: 259832
GnomAD4 exome
AF:
AC:
745
AN:
901940
Hom.:
Cov.:
15
AF XY:
AC XY:
233
AN XY:
259832
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000859 AC: 96AN: 111783Hom.: 0 Cov.: 23 AF XY: 0.00133 AC XY: 45AN XY: 33957
GnomAD4 genome
AF:
AC:
96
AN:
111783
Hom.:
Cov.:
23
AF XY:
AC XY:
45
AN XY:
33957
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 16, 2022 | See Variant Classification Assertion Criteria. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at